Latest News
Tesla Stock Edges Up After Musk's $115B Share Filing; Capex and Robotaxi Plans in Focus
Tesla (TSLA) shares closed at $378.67, up 0.6%, after registering 303.96 million shares linked to Elon Musk's 2018 CEO award, valued at $114.65 billion. The market weighed dilution concerns against Tesla's $25 billion 2026 capex plan and robotaxi timeline.
Interstellar Comet 3I/ATLAS Bears Water Signature from Frigid Exoplanetary System
ALMA measurements of deuterated water in interstellar comet 3I/ATLAS show a D/H ratio over 40 times Earth's oceans, indicating origin in a far colder system.
Stanley Black & Decker Shares Surge on $500M Buyback Plan
Stanley Black & Decker shares climbed 4% to $79.86 after the board approved a $500 million buyback and kept the quarterly dividend at $0.83 per share. Q1 results are due Wednesday.
Oruka Therapeutics Soars on Psoriasis Drug Data, Announces $500M Offering
Oruka Therapeutics shares surged after interim data showed its psoriasis drug ORKA-001 achieved 63.5% complete skin clearance. The company also announced a $500M public offering.
Rambus Stock Declines Despite AI-Driven Revenue Growth in Q1
Rambus shares dropped 10.8% after Q1 earnings, despite product revenue climbing 15% on AI demand. The company's cautious Q2 outlook tied to customer deals tempered investor enthusiasm.
Edesa Biotech Surges 54% on Renewed ARDS Drug Optimism
Edesa Biotech (EDSA) shares surged 54% on Monday, driven by renewed interest in February data showing paridiprubart reduced 28-day ARDS mortality to 24% from 33%.
Celestica Shares Dip Despite Strong Earnings and Raised AI-Driven Guidance
Celestica reported Q1 revenue of $4.05B, up 53% YoY, and raised its 2026 outlook to $19B, but shares slipped as the market had already priced in strong AI demand.
XRP Dips 2.7% to $1.39 Despite Ripple-K Bank Pilot, Stablecoin Focus Caps Rally
XRP slipped 2.7% to $1.39 on Monday as Ripple's new pilot with K Bank uses stablecoins, not XRP. The broader crypto market also declined, with bitcoin near $76,960.
AMD Shares Slide on Downgrade Amid AI Rally Skepticism
AMD shares dropped 3.8% after a Northland Capital downgrade questioned the AI rally's sustainability, while Nvidia and Intel gained.
Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial
Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.
Spotty Earnings Ahead: Spotify Launches Peloton Fitness Content
Spotify launches a fitness category with Peloton classes for Premium users, expanding beyond audio. SPOT stock falls ahead of Q1 earnings, while PTON rises.
McDonald's Shares Slide on Downgrade Amid Value War and Netflix Promotion
McDonald's shares dropped nearly 3% after Erste Group downgraded the stock to Hold, citing slower profit growth. The company's upcoming Netflix Happy Meal promotion faces a challenging fast-food environment.